Dr. Marc Tessier-Lavigne is a President at Stanford University, an Independent Director at Denali Therapeutics, Inc., an Independent Director at Regeneron Pharmaceuticals, Inc., a Member at American Philosophical Society, a Member at Institute of Medicine, a Member at National Academy of Medicine of United States, a Member at National Academy of Sciences, a Member at Royal Society of Canada and a Member at The Royal Society. He is on the Board of Directors at Denali Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., Federal Reserve Bank of New York, Stanford Alumni Association, The Rockefeller Archive Center and Bay Area Council Economic Institute. Dr. Tessier-Lavigne was previously employed as an Independent Director by Juno Therapeutics, Inc., an Independent Director by Pfizer Inc., a Chairman by Agios Pharmaceuticals, Inc., a President, Trustee & Professor by The Rockefeller University, a Chief Scientific Officer & Executive VP-Research by Genentech, Inc., a Founder by Renovis, Inc., and a Professor by The University of California, San Francisco. He also served on the board at The Aaron Diamond AIDS Research Center. He received his undergraduate degree from the University of Oxford, an undergraduate degree from McGill University and a doctorate degree from the University College London.